Erectile Dysfunction in Young Men: A Review of Prevalence and Risk Factors

June 2017 in “ Sexual Medicine Reviews ”

Hoang Minh Nguyen, Andrew Gabrielson, Wayne J.G. Hellstrom

Studysummary This review discusses the increasing prevalence of erectile dysfunction in young men and emphasizes the importance of identifying specific causes for effective management, reporting no new clinical results. Our plain-language summary of this paper — not a Tressless recommendation.

The 2017 review indicated that erectile dysfunction (ED) in young men under 40 years is increasingly common, with prevalence estimates up to 30%. It identified both psychogenic and organic causes, including depression, anxiety, partner-related issues, vascular and structural conditions, endocrine disorders, neurogenic conditions, and medication side effects. Medications like antidepressants, NSAIDs, and finasteride were noted as potential contributors, with a study showing 1.4% of finasteride users had ED compared to 0.9% in the placebo group. The review also linked ED with underlying diseases like cardiovascular disease and diabetes and emphasized the importance of addressing both physical and psychological aspects for effective management. Treatment options for young men with ED included PDE5 inhibitors as the first-line treatment, intracavernosal injections, intraurethral suppositories, penile revascularization, and other treatments, while stem cell therapies were not recommended outside of clinical trials. The review stressed the need for clinicians to screen for and consider various risk factors when treating ED in younger men.

View this study on sciencedirect.com →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

Sexual Dysfunction in Subjects Treated with Inhibitors of 5α-Reductase for Benign Prostatic Hyperplasia: A Comprehensive Review and Meta-Analysis

research Sexual Dysfunction in Subjects Treated with Inhibitors of 5α-Reductase for Benign Prostatic Hyperplasia: A Comprehensive Review and Meta-Analysis

66 citations , April 2017 in “International Journal of Andrology”

This study found that 5α-reductase inhibitors significantly increase the risk of erectile dysfunction and hypoactive sexual desire in men with benign prostatic hyperplasia, compared to placebo.

research Organic Causes of Erectile Dysfunction in Men Under 40

2152 citations , November 2013 in “Urologia Internationalis”

This study reviews the significant prevalence of organic etiologies, especially vascular causes, in erectile dysfunction among men under 40 and emphasizes thorough evaluation and consideration of treatment options like exercise and PDE-5 inhibitors.

research Finasteride in the Treatment of Men with Androgenetic Alopecia

581 citations , October 1998 in “Journal of The American Academy of Dermatology”

In male pattern hair loss, this study found that finasteride 1 mg daily significantly slowed hair loss and increased hair growth over two years compared to placebo.